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INTRODUCTION
The main causes of infant morbidity and mortality
are obstetrics and perinatology problem. It is close
to preterm birth. 70% of neonatal morbidity and
mortality are caused by prematurity. More than
65% of neonatal deaths occur in infants born
preterm, with a mortality rate of 19,000 per
year.1,2 American College of Obstetrician and
Gynecologist (ACOG) stated that the definition of
preterm labor is labor that occurs before 37 weeks
gestation or less than 259 days from the first day
of the last menstrual period (LMP). Meanwhile,
according to the World Health Organization
(WHO), preterm birth is defined as birth that
occurs before 37 weeks gestation, with intact fetal
membrane.3 In outline, preterm labor are classi-
fied into three major groups, there are: 25% of
preterm labor occurs with indication of unstable
condition of mother or fetal status. Preterm
rupture of membranes cause 30% of preterm
labor, whereas preterm labor that occurs spon-
taneously without prior rupture of membranes
40-50%, with half the cause is ascending infec-
tion on genital tract that causes intrauterine
infection.2,4
Some literature states that infection and
inflammation lead to more than 50% of preterm
pregnancies.5 Significant increase of inflammatory
mediators will trigger a substance released as
regulator of inflammatory response. Protease
inhibitors act as inflammatory response regulator
as well as inhibitors to the elastase products.6
Secretory leukocyte protease inhibitor (SLPI) is
the most potent protease inhibitor in inhibiting the
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Abstrak
Tujuan: Untuk mengetahui kadar secretory leukocyte protease inhibi-
tor (SLPI) pada persalinan dan kehamilan prematur.
Metode: Dilakukan pemeriksaan kadar SLPI pada 32 sampel ibu
hamil yang memenuhi kriteria inklusi dan eksklusi, terdiri dari 16persalinan prematur dan 16 kehamilan prematur. Analisis sampel
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menggunakan metode ELISA. Data yang diperoleh diolah denganmenggunakan perangkat lunak SPSS versi 20.0 dan dilakukan
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inflammatory process against Neutrophil Elastase
(NE) that can cause the cervix to soften. Secretory
leukocyte protease inhibitor excreted during
pregnancy with the highest concentration found on
the cervical mucus and serves as the main barrier
to infection in the genital tract during pregnancy.
SLPI secreted dominantly by the decidua, espe-
cially the parietal decidua and korio decidua.
Lower levels secreted by the amnion and
placenta.7,8 Increasing concentrations of SLPI
would form inflammatory interactions in
maintaining a pregnancy and then limit it during
delivery. Anti-microbiological effects caused by
SLPI would protect the uterus during implantation
and prevent infection during pregnancy.3,5,7 Based
on the function of SLPI above, research conducted
with the aim to determine the concentration
differences of SLPI in preterm labor and preterm
pregnancy with intact membranes, and determine
SLPI cutoff point to predict the preterm labor
incidence.
METHOD
In this research, the design used was cross-
sectional by comparing concentrations of
Secretory Leukocyte Protease Inhibitor (SLPI)
on research subjects serum, among preterm
labor without preterm rupture of membranes and
preterm pregnancy. This research conducted in
Section / SMF Obstetrics and Gynecology Faculty
of Medicine, Universitas Sam Ratulangi, Prof. Dr.
R.D. Kandou Central General Hospital Manado and
network hospitals Department of Obstetrics and
Gynecology Faculty of Medicine Universitas Sam
Ratulangi, began in September 2016 until the
samples quantity fulfilled. The samples were
pregnant women who experience preterm labor in
the delivery room of RSUP Prof. Dr. R. D. Kandou
Manado and network hospital that met the
inclusion criteria. The control group was 20-36
weeks pregnant women who checkups in Obstetric
Polyclinic RSUP Prof Dr. R.D. Kandou Manado and
network hospital. Sample collected by consecutive
sampling where every subject which met the
research criteria included in the research up to a
certain time until the number of samples fulfilled.
The inclusion criteria were 20-36 weeks pregnant
women based on the first day of the last menstrual
period, active phase labor stage 1, live singleton
pregnancies lies the head, intact membranes, no
complications or obstetric complications, and pa-
tients willing to participate in research and signed
an informed consent sheet. While exclusion criteria
were pregnant women with preterm labor history
in previous pregnancy, has systemic infection on
the subject, there are congenital malformations in
the fetus, and refused to follow the research.
The number of samples using single mean
formula with reference to the SLPI concentration
in women with intact membranes preterm labor
i.e. 698 g/l (ranges: 320-1054 g/l; standard
deviations assumption 250 g/l).
n = number of samples = 15.4 = 16
Z = 1.96
 = standard deviation = 250 g/l
d = desired accuracy = 125 g/l
So number of samples = 32 (each of the 16
women with intact membranes preterm labor 16
women with intact membranes term labor). The
statistical test is t-test (independent samples; 2
mean difference), or equivalent non-parametric
tests, i.e. the Mann-Whitney test. The cut-off point,
sensitivity, and specificity will be determined using
analysis of Receiver Operating Curve (ROC).
RESULT
A total 32 subjects consisting of 16 pregnant
women who experienced preterm labor and 16
pregnant women with preterm pregnancy were
recruited. Characteristics of the subjects are pre-
sented in Table 1.
Table 1. Characteristics Subject on Both Group Research
Characteristic
Preterm Labor Preterm Pregnancy
n % n %
Age
 24 7 43.75 5 31.25
25-34 7 43.75 5 31.25
>34 2 12.5 6 37.5
Parity
0 3 18.75 5 31.25
1 5 31.25 4 25
( )n = Z2  = 15.4 = 16d2
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2 5 31.25 4 25
3 1 6.25 1 6.25
4 2 12.5 2 12.5
Mass Body Index
< 19.8 2 12.5 - 0
19.9 - 26 8 50 7 43.75
26.01 - 29.99 5 31.25 6 37.5
> 30 1 6.25 3 18.75
Antenatal Care
< three times 7 43.75 6 37.5
 four times 9 56.25 10 62.5
Left Upper Arm
Circumference
 23.5 2 12.5 2 12.5
> 23.5 14 87.5 14 87.5
From the above data obtained maternal age in
the group of preterm labor <24 years as many as
seven people (43.75%) and ages 25-34 years as
many as seven people (43.75%). Whereas in the
group of preterm pregnancy obtained age group
<24 years as many as five people (31.25%), and
ages 25-34 years as many as five people (31.25%).
The highest Parity in the group preterm labor is
parity 1 and 2 i.e. 5 people for each with a percent-
age 31.25%. While groups of preterm pregnancy
who present in the obstetric polyclinic the majority
were parity 0 as many as five people (31.25%). The
body mass index in the group of preterm labor di-
vided into four groups. The highest number was
found in the body mass index between 19.9 to 26
as many as eight peoples (50%). Whereas in the
group of preterm pregnancy that went to the
obstetric polyclinic have highest body mass index
from 19.9 to 26 as many as seven people (43.75%).
Antenatal care visit in preterm labor group the
most are  four times as many as nine people
(56.25%). Whereas in preterm pregnancy group
most patients have antenatal care regularly, i.e.,
ten people (62.5%) do antenatal care  four times.
Left upper arm circumference measurements in
preterm labor group most obtained > 23.5 cm as
many as 14 people (87.5%). Whereas in the group
of preterm pregnancy who present at the polyclinic
obtained measurements of left upper arm circum-
ference > 23.5 cm as many as 14 people (87.5%).
Table 2. Descriptive SLPI Distribution Level Data
Group Preterm Labor Preterm Pregnancy
Mean 45.975 30.319
Median 41.600 29.950
Interval for mean 41.198 - 50.752 27.794 - 32.844
Standard Deviation 8.9641 4.7389
Range 25.3 16.5
Table 3. SLPI Variable Normality Test (Shapiro Wilk Test)
Group p­value
Preterm Labor 0.005
Preterm Pregnancy 0.652
From Table 2 obtained SLPI concentration ratio
between preterm labor and preterm pregnancy. In
preterm labor group, obtained mean value for SLPI
concentration is 30.319 with standard deviation
4.7389, median 29.950, range 16.5 and the ranges
obtained 27.794 - 32.844. In preterm pregnancy
group obtained mean value for SLPI concentration
45.975 standard deviations 8.9641, median 41.600,
range 25.3 and the range obtained between 41.198
- 50.752.
From the data Shapiro-Wilk normality test seen
levels of secretory leukocyte protease inhibitor
(SLPI) in preterm pregnancy group is not normally
distributed (one of them p <0.05), so Mann-Whit-
ney test will be conducted as non-parametric test.
Mann-Whitney non-parametric test showed that
p = 0.000 which means that there are significant
differences between SLPI level of preterm preg-
nancy and preterm labor. Conclusion SLPI levels
and preterm labor correlate.
Figure 1. Graphs the Level of SLPI in Preterm Labor and
Preterm Pregnancy
Pregnant Preterm Labor
Group
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From those data ROC (Receiver Operating
Characteristic) curve made to determine the cut-off
point of SLPI concentration, i.e., 37.9 ng/ml with
sensitivity 100% and specificity 93.7%.
DISCUSSION
Some research says that many demographic factors
that imply the risk of preterm labor threat. In term
of epidemiology, there are several risk factors for
preterm labor, which are9-11:
Idiopathic, Iatrogenic, such as aggravate circum-
stances to mother or fetus, Infections, both extra
and intrauterine, multiple pregnancies, maternal
factors: stress in mothers, cervical incompetence,
disease in mothers, reproductive history: previous
prematurity history, ruptured membranes history,
abortion history, primipara, too close spaced
pregnancies, low maternal weight gain during
pregnancy, parity, sociodemographic: low socio-
economic, too young or too old age, race, marital
status, unfavorable environmental factors, too
heavy daily activities.
A prematurity history in the elderly will be a
potentially important factor for the prematurity
back in the offspring. Another meta-analysis also
noted that prematurity history or intrauterine
infection would cause carrier to cytokine inflam-
matory mediators, and its correlation with geno-
typic researched continuously.4,12
In this research, from the characteristic table
showed that the incidence of preterm labor was
highest at age less than 24 years and the age of
25-34 years. Too young or too old maternal age
also a risk factor for preterm labor. Research in
Sweden mentioned that the maternal age during
pregnancy between 13-17 years of age increases
the risk of preterm labor twice control age of 20-24
years. While on maternal age over 35 years in-
creases the risk of preterm labor twice compared
with control age of 20-30 years.5 According to
creasy, maternal age relationship to preterm labor
is the younger the maternal age, the greater the
risk preterm labor. Maternal age less than 20 years
and maternal age over 40 years has a risk for
preterm labor. Maternal age less than 18 years old
have greater risk score than 20 years. The preterm
labor incidence is much found at younger age due
to such factors: socioeconomic, education, and life-
style habits.9,13
Based on some research, preterm labor is more
common in primipara. And some research also
indicates the preterm labor risk increased in
pregnancies of more than four.6,7 In this research
obtained highest preterm labor occurred in women
with parity 1 and 2.14 In the table of research
subject characteristics, based on the body mass
index obtained the highest number of preterm
labor occurrences is 19.9 to 26 for eight patients.
Cohen et al. mentioned significant relationship
between low maternal body weight or low BMI
during pregnancy with preterm labor incidence.
Low maternal body weight or low BMI during
pregnancy as well as poor nutrition also risk factor
for preterm labor.15,16 Some anthropometric
examination can be used to determine the nutri-
tional status of pregnant mother, one of which is
by measuring Left Upper Arm Circumference
(LUAC). Through this examination can predict
mother experiencing Chronic Energy Deficiency
(CED) if LUAC < 23.5 cm. Lack of energy has the
risk to deliver a baby with low birth weight and
increase the risk to preterm labor.12,17 From the
MUAC measurement characteristic table in this
research, in preterm labor group obtained only
two people with LILA measurement < 23.5 cm.
SLPI  Concentration  in  Preterm  Labor  and
Preterm Pregnancy
SLPI serves as a potent inhibitor and immunity
in an inflammatory process, by reducing the
inflammatory genes expression and reduce cells
inflammatory accumulation, as well as contributing
to the immunity balance. In broad outline, SLPI has
anti-inflammatory activity, anti-virus, and anti-
Figure 2. ROC (receiver operating characteristic) Cut off
Point of SLPI.
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bacterial.18,19 SLPI concentration increased from
the second trimester to the third trimester, al-
though the concentration changes and activities
at the labor onset has not been widely re-
searched.20-22 Denison et al. mentioned that SLPI
in the amniotic fluid concentration continued to
increase since the second trimester until term
pregnancy, and at the labor onset. In the second
trimester obtained SLPI concentration 24  three
ng/ml, whereas the term pregnancy SLPI concen-
tration is 751  53 ng/ml. The highest concentra-
tion of SLPI obtained in term labor onset i.e. 3929
 107 ng/ml.20
Zhang et al., In their research mentioned that
SLPI concentration in the amniotic fluid third tri-
mester of pregnancy (802  138 ng/ml) higher
than SLPI concentration in the second trimester of
pregnancy (106  15 ng/ml) with the significance
value p < 0.0001. Helmig et al., mentioned that in
preterm pregnancy with preceded rupture mem-
brane, has an SLPI concentration average value in
amniotic fluid lower that intact membrane, i.e., 579
g/l in rupture membrane pregnancy and 1038
g/l in intact membrane pregnancy.23 From some
of conducted research, it can be concluded that the
increased SLPI with age pregnancy serves to main-
tain the pregnancy of inflammatory process that
can cause preterm labor. Several studies of the low
concentration of SLPI in the amniotic fluid in
preterm rupture case due to lower anti-protease
activity, where in the protease has the ability in
membrane degradation that can soften and ripen
the cervix. SLPI concentration reduction will result
in decreased in SLPI antimicrobial effect to the
uterus, that can cause infection and lead to preterm
labor.24,25
This is consistent with research conducted by
Punchner et al. where SLPI concentration assessed
in spontaneous preterm labor with prior rupture
preterm labor. From these studies obtained low
concentrations of SLPI in prior rupture preterm
labor case. Theoretically can be explained that the
low concentration of SLPI in rupture of membranes
associated with the inflammatory process. In this
research, research conducted on 16 patients with
preterm pregnant mother compared with 16
patients mothers who experience preterm labor
without ruptured membranes. Blood sampling
performed on all samples and tested in the labo-
ratory. Then conduct Mann - Whitney non-para-
metric test which showed that p = 0.000 which
means obtained statistically significant difference
of SLPI concentration values between groups of
preterm labor and preterm pregnancy. So the re-
sults of this research can prove that low levels of
SLPI is one of the preterm labor causes.
SLPI Cut Off Point
Some research that done previously stated, there
is a tendency to lower concentration of SLPI in pre-
term labor case, by using amniotic fluid as SLPI
concentration inspection material. However, some
researchers got different SLPI concentration values
and still have not found SLPI concentration cut off
point to be used as a predictor of preterm labor
without prior rupture. In this research, based on
ROC curve obtained SLPI concentration cut off
points mark of the preterm labor incidence is 37.9
ng/ml. If the SLPI concentration value  37.9 in
women with a gestational age <37 weeks may
lead to preterm labor with sensitivity 100% and
specificity 93.7%. Expected the SLPI concentration
assessment result in this research can serve as
guidelines to predict preterm labor risk during
antenatal as early detection.
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